Stay updated on Nivolumab vs Temozolomide in GBM Clinical Trial
Sign up to get notified when there's something new on the Nivolumab vs Temozolomide in GBM Clinical Trial page.

Latest updates to the Nivolumab vs Temozolomide in GBM Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedRevision tag updated from v3.3.1 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check21 days agoChange DetectedAdded a note that publications are automatically filled from PubMed and that the page now displays Revision: v3.3.1. Removed the older PubMed-origin wording and Revision: v3.2.0 reference.SummaryDifference0.0%

- Check29 days agoChange DetectedThe government funding status notice at the top of the page was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check43 days agoChange DetectedNo significant additions or deletions were detected on the Study Details page. The study design, eligibility criteria, and listed locations remain the same.SummaryDifference0.2%

- Check71 days agoChange DetectedAdded a government-operating-status notice and a new publication citation; updated the revision to v3.2.0 (replacing v3.1.0).SummaryDifference4%

- Check79 days agoChange DetectedPage revision updated from v3.0.2 to v3.1.0, indicating a version bump with no other substantive content changes.SummaryDifference0.1%

Stay in the know with updates to Nivolumab vs Temozolomide in GBM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab vs Temozolomide in GBM Clinical Trial page.